Capnia, Inc. develops diagnostics and therapeutics based on its proprietary technology for precision gas flow measurement primarily in the United States. The company is headquartered in Redwood City, California.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 5.85% |
| Return on Assets | -0.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.42 |
| Price-to-Book | 0.95 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -28.30% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $5.29M |
| Float | $1.85M |
| % Insiders | 70.78% |
| % Institutions | 104.88% |
Volatility is currently contracting